Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bowen

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
Transfusion Medicine (Oxford, England)|June 15, 2007
Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004P Fenaux, J M Bennett, D T Bowen, et al.
Biology of Sex Differences|July 19, 2024
Sex differences in the social motivation of rats: Insights from social operant conditioning, behavioural economics, and video trackingJoel S Raymond, Simone Rehn, Morgan H James, et al.
Computer Methods in Biomechanics and Biomedical Engineering|September 5, 2020
Statistical shape modeling of the pelvic floor to evaluate women with obstructed defecation symptomsMegan R Routzong, Ghazaleh Rostaminia, Shaniel T Bowen, et al.
Leukemia|November 1, 1993
Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spotsD T Bowen, R A Padua, A K Burnett, et al.
British Journal of Pharmacology|May 28, 2025
Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT<sub>1A</sub> receptor mechanism: Exploration of other potential receptor targetsConnie J Badolato, Erin A Lynch, Jonathon C Arnold, et al.
Blood|March 9, 2000
Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposureR R West, D A Stafford, A D White, et al.
British Journal of Haematology|December 24, 1997
Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentrationC M Peddie, C R Wolf, L I McLellan, et al.
Haematologica|July 20, 2004
NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q)Carrie Fidler, Fiona Watkins, David T Bowen, et al.
British Journal of Haematology|April 2, 2005
Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemiaM F Johan, D T Bowen, M E Frew, et al.
British Journal of Haematology|September 15, 2005
JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemiaM F Johan, A C Goodeve, D T Bowen, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Transfusion Medicine (Oxford, England)|June 15, 2007
Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004P Fenaux, J M Bennett, D T Bowen, et al.
Biology of Sex Differences|July 19, 2024
Sex differences in the social motivation of rats: Insights from social operant conditioning, behavioural economics, and video trackingJoel S Raymond, Simone Rehn, Morgan H James, et al.
Computer Methods in Biomechanics and Biomedical Engineering|September 5, 2020
Statistical shape modeling of the pelvic floor to evaluate women with obstructed defecation symptomsMegan R Routzong, Ghazaleh Rostaminia, Shaniel T Bowen, et al.
Leukemia|November 1, 1993
Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spotsD T Bowen, R A Padua, A K Burnett, et al.
British Journal of Pharmacology|May 28, 2025
Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT<sub>1A</sub> receptor mechanism: Exploration of other potential receptor targetsConnie J Badolato, Erin A Lynch, Jonathon C Arnold, et al.
Blood|March 9, 2000
Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposureR R West, D A Stafford, A D White, et al.
British Journal of Haematology|December 24, 1997
Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentrationC M Peddie, C R Wolf, L I McLellan, et al.
Haematologica|July 20, 2004
NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q)Carrie Fidler, Fiona Watkins, David T Bowen, et al.
British Journal of Haematology|April 2, 2005
Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemiaM F Johan, D T Bowen, M E Frew, et al.
British Journal of Haematology|September 15, 2005
JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemiaM F Johan, A C Goodeve, D T Bowen, et al.
Pageof 28